Abstract 2127P
Background
Yoga has gained more attention worldwide in the last decade and shown the potential to improve physiological and psychological health in various disease conditions. Studies on breast cancer (BC) survivors showed mild to moderate effects within one-month to six-month on various parameters. Cancer treatment-related side effects are often related with functional as well as symptomatic scales. Therefore, we have conducted a randomized control study to find out the effect of long-term yogic intervention on symptom and functional scale in patients undergoing treatment.
Methods
This study was approved by the institutional ethics committee. The current study consisted of 96 BC stage II/III patients receiving cancer treatments who were randomly divided into two groups: Group-I (non-yoga) and Group-II (yoga). Group-II was advised to perform yoga 5 days per week for 48 weeks and was monitored regularly by video or phone calls. At different time points (T0 (baseline), T1 (16th week), T2 (32nd week), and T3 (48th week), we collected the breast cancer specific questionnaire (EORTC-BR23), which consisted of various functional scales (body image, sexual functioning, sexual enjoyment, future perspective) and symptomatic scales (systemic therapy side effects, breast symptoms, arm symptoms, upset by hair loss), and compared them between groups as well as within group.
Results
Out of 96 total patients, 82 were analyzed for T0-T3 (40 in group-I and 42 in group-II). In groups I and II, the mean age was 47.67±11.68 and 43.11±9.39, respectively. Yogic intervention resulted in a significant improvement in arm symptoms and side effects from T0 to T3 (p<0.001) and T1 to T3 (p<0.01) in group II, while group I also improved from T0 to T3 (p<0.05). The most significant difference was observed in Group-I (T0) vs. Group-II (T3). There was no significant difference observed in upset by hair loss, body image, breast symptoms, or future perspective.
Conclusions
The duration of yoga positively correlated with the systematic therapy side effects and improved their arm symptoms. This suggested that yogic intervention during therapy could be an effective complementary therapy.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2115P - Pre-cachexia incidence in patients with solid cancer: A cross-sectional study
Presenter: Lynn Gottmann
Session: Poster session 06
2116P - Preoperative body mass index, waist circumference, and mortality after major cancer surgery: A nationwide cohort study in South Korea
Presenter: Jiwon Yoon
Session: Poster session 06
2117P - Dietary patterns and clinical outcomes in patients with lung cancer: What needs to change
Presenter: Imanuely Borchardt
Session: Poster session 06
2118P - Refeeding syndrome: A prospective analysis in adults admitted to an oncology hospital
Presenter: Filipe Gonçalves
Session: Poster session 06
2119P - The prognostic impact of nutritional assessment and scores in advanced gastric cancer
Presenter: Sara Torresan
Session: Poster session 06
2120P - Nutritional deficiency post gastric cancer surgery
Presenter: Abay Makishev
Session: Poster session 06
2121P - Association between nutritional status and adverse events in gastrointestinal cancer patients undergoing outpatient chemotherapy in Japan
Presenter: Naoko Sato
Session: Poster session 06
2122P - Clinical significance of oncology patients’ nutritional status assessment
Presenter: Efthymios Kostaridis
Session: Poster session 06
2123P - Value of immuno-nutritional scores in the prognosis of hospitalised patients with lung cancer
Presenter: Jesús López
Session: Poster session 06
2124P - The impact of NUTRItional status at first medical oncology visit ON Clinical Outcomes: The NUTRIONCO study
Presenter: Maurizio Muscaritoli
Session: Poster session 06